Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II

被引:25
作者
Baragatti, B
Biagi, G
Calderone, V
Giorgi, I
Livi, O
Martinotti, E
Scartoni, V
机构
[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
[2] Univ Pisa, Dipartimento Psichiat Neurobiol Farmacol & Biotec, I-56126 Pisa, Italy
关键词
1,2,3-triazoles; benzotriazoles; benzimidazolones; potassium channel activators;
D O I
10.1016/S0223-5234(00)01170-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This paper reports the synthesis and pharmacological evaluation of a series of 5-substituted-triazolyl-benzotriazoles (2a-f) and the corresponding series of 5-substituted-triazolyl-benzimidazolones (6a-f), as potential activators of the big-conductance calcium-activated potassium channels (BKCa). The synthesis and structure demonstration of the stock compounds of the two series have been described in our previous works, as well as the common starting compounds 4-carboxamido-5-(4-substituted-2-amino-anilino)-1,2,3-triazoles (1a-f). The triazolyl-benzotriazoles were obtained by diazotization, while the triazolyl-benzimida-zolones were obtained by thermal intramolecular cyclization of ethoxycarbonylamino derivatives or directly with phosgene. Benzimidazolone compounds generally showed little effect whilst the compounds with a benzotriazole ring showed full efficacy, with vasorelaxing properties and potency parameters a little lower than that of the reference compound NS 1619. These effects were significantly reduced by an increased membrane depolarization. This depolarization-sensitive response is in agreement with the pharmacodynamic hypothesis of activation of potassium channels. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:949 / 955
页数:7
相关论文
共 10 条
[1]  
BERTELLI L, IN PRESS J HETEROCYC
[2]   New 4-(benzotriazol-1-yl)-1,2,3-triazole derivatives [J].
Biagi, G ;
Giorgi, I ;
Livi, O ;
Scartoni, V ;
Velo, S ;
Barili, PL .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1996, 33 (06) :1847-1853
[3]   5-(4′-substituted-2′-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators.: I [J].
Biagi, G ;
Calderone, V ;
Griorgi, I ;
Livi, O ;
Scartoni, V ;
Baragatti, B ;
Martinotti, E .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (7-8) :715-720
[4]  
Cook N., 1990, POTASSIUM CHANNELS S
[5]  
ELLIS GP, 1992, SYNTHESIS FUSED HE 2
[6]   Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings [J].
Magnon, M ;
Calderone, V ;
Floch, A ;
Cavero, I .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (04) :452-463
[7]  
OLESEN SP, 1974, Patent No. 617023
[8]  
PRESTON PN, 1981, BENZIMIDAZOLES CON 1
[9]  
SARGENT CA, 1993, J PHARMACOL EXP THER, V266, P1422
[10]   Synergistic action of NS-004 and internal Ca2+ concentration in modulating pulmonary artery K+ channels [J].
Vandier, C ;
Bonnet, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (01) :53-60